We are LOTTE Biologics! A new company, built on 80 years of tradition!
We embody our core values of being Inspired by Science, Embracing Diversity, Fostering Talent, and Connecting Lives. Our mission is to be the most trusted partner in the industry, with high standards of quality and continuous innovation, to reliably deliver benefits for patients worldwide.
We deliver therapies that make a Healthier World!
To help us meet our mission LOTTE Biologics is in need of a Director, Manufacturing Sciences & Technology (MS&T) who will be will be accountable for developing, managing, and retaining bench strength and leadership across the MS&T function through coaching, mentoring, and providing development opportunities to the following teams: Manufacturing Support, Upstream and Downstream Process Development, and Analytical Science and Technology. The Director, MS&T will liaise with clients and partner organizations to transfer and support new product introduction and development, improvements, troubleshooting, investigation and commercializing of manufacturing processes and analytical methods. The successful candidate will have strong technical, scientific, management and leadership skills, experience in early process development through commercialization of biologics, process and analytical technology transfer, project management and the ability to influence across functions. The role will report to the General Manager and will drive the analytical and process CMC throughout the product life cycle.
Education & Experience
We believe that women, people of color, veterans and LGBTQ communities must participate in the work we do, so we strongly encourage applications from people with these identities or who are members of underrepresented communities. If this is the work that you want to do in a culture of inclusion and excellence with the goal of making our world to be a healthier place, then please apply today!
LOTTE BIOLOGICS was established in 2022, and is headquartered in Seoul, South Korea. LOTTE BIOLOGICS entered the biologics CDMO business after acquiring Bristol Myers Squibb’s Syracuse biologics drug substance manufacturing site, as of January 1, 2023!
The newly established organization aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. With initial operations in 1948 in Japan, LOTTE has grown to become the fifth-largest conglomerate corporation in South Korea. LOTTE has various business units, including petro/fine chemicals, food, retail, hotels, electronics, construction, and IT. LOTTE has 30+ global locations across the US, Europe, and Asia.
An Equal Opportunity Employer
We do not discriminate based on race, color, religion, national origin, sex, age, disability, genetic information, or any other status protected by law or regulation. It is our intention that all qualified applicants are given equal opportunity and that selection decisions be based on job-related factors.